Cromos Pharma continues to battle COVID-19

It has been over two and a half years since the COVID-19 pandemic began. Its effects have been far-reaching, and many economies and societies around the world came to a standstill, but there was an even higher price to be paid. In a relatively short amount of time, almost 6,5 million people died from this devastating illness, an astronomically high number when compared to other viral outbreaks from the last few decades.  

COVID-19 Clinical Trials

Today mankind is facing a new wave of pandemic and confirmed cases around the world are skyrocketing once again. Luckily, we have gained a lot of wisdom on how we can combat this unrelenting virus, and the world is no longer as vulnerable. There are many new methods of treatment for the infection, and many more are being developed. There are many ongoing clinical trials of various drugs and vaccines for the prevention and treatment of COVID-19. 

So far, the total number of ongoing and completed COVID-19 studies, listed on the World Health Organization’s International Clinical Trials Registry Platform (WHO ICTRP), stands at 6914. According to Clinicaltrials.gov statistics, there are 3057 recruiting and not yet recruiting trials for COVID-19 globally, including 668 active vaccine studies, and 1074 for COVID-19 treatment.

Why Choose Cromos Pharma?

Cromos Pharma has gained a wealth of experience with COVID-19 clinical trials. We can proudly say that our CRO was one of the first companies that played a part in the fight against the pandemic. As early as April 2020 we initiated global clinical trials to treat severe COVID-19 infection. Throughout 2021-2022 Cromos Pharma has been conducting successful COVID-19 clinical trials contributing to the global effort to find new treatments. We are currently launching two new treatments and one vaccine trial in various geographies that we cover. We remain committed to making the world a safer place, one clinical trial at a time.

About Cromos Pharma

Cromos Pharma is a US-based, international contract research organization delivering fully integrated clinical research solutions, in all trial phases, across a wide range of therapeutic indications. Our expert team, comprised of 95% MDs, has extensive expertise in study design, medical writing, regulatory affairs, site management, patient recruitment and data management.

Cromos Pharma has experience in delivering success in a wide range of trial types, from biosimilars and generics, to successfully managing trials of novel therapeutics in a wide range of clinical indications. Our team provides full-service solutions to international pharma and biotech companies in high-recruiting regions, assuring exceptional data quality. Cromos Pharma combines global expertise with in-depth experience and knowledge in the US, Central and Eastern Europe, Central Asia, Republic of Georgia, and Türkiye to offer exceptional patient recruitment. Our team has met or reduced enrollment timelines in 95% of conducted trials.

We provide accelerated study start-up timelines in our regions of operation. Regulatory inspections by FDA and EMA and site audits attest to the highest quality of our clinical data.

Established in 2004, Cromos Pharma has strong regional experience that is supported by a global network of offices. Its international HQ is located in Portland, Oregon, USA and its European HQ is in Dublin, Ireland.

If you have any questions or want to find out more about how Cromos Pharma can support your next clinical program please get in touch with us by emailing inquiry@cromospharma.com.